• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.39% Nasdaq Down 0.32%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.00 Down 0.06(1.48%) 1:58PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:4.06
    Open:4.07
    Bid:4.00 x 8900
    Ask:4.01 x 3800
    1y Target Est:7.70
    Beta:-0.62
    Next Earnings Date: 5-Aug-15ARNA Earnings announcement
    Day's Range:3.95 - 4.08
    52wk Range:3.26 - 6.28
    Volume:870,680
    Avg Vol (3m):2,572,700
    Market Cap:968.16M
    P/E (ttm):N/A
    EPS (ttm):-0.27
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNADown 1.48%968.16M
    GSKDown 0.13%104.94B
    OREXDown 1.92%486.35M
    RHHBYUp 0.22%245.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):23.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.51
    Quarterly EPS Est (Jun-15) :-0.14
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):0.39

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback